These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8435477)

  • 1. Evaluation of cathepsin D as a prognostic factor in breast cancer.
    Ravdin PM
    Breast Cancer Res Treat; 1993; 24(3):219-26. PubMed ID: 8435477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to P.M. Ravdin (BCRT 24:219-226, 1993), "Evaluation of Cathepsin D as a Prognostic Factor in Breast Cancer".
    Rochefort H; Thorpe S
    Breast Cancer Res Treat; 1993; 26(1):107-11. PubMed ID: 8400319
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of cathepsin D as prognostic predictor in breast cancer.
    Barbi GP; Margallo E; Margiocco M; Paganuzzi M; Marroni P; Costanzi B; Gatteschi B; Tanara G; Spina B; Nicolò G
    Oncology; 1994; 51(4):329-33. PubMed ID: 8208515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cathepsin B, a prognostic indicator in lymph node-negative breast carcinoma patients: comparison with cathepsin D, cathepsin L, and other clinical indicators.
    Lah TT; Cercek M; Blejec A; Kos J; Gorodetsky E; Somers R; Daskal I
    Clin Cancer Res; 2000 Feb; 6(2):578-84. PubMed ID: 10690542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombospondin-1 and -2 in node-negative breast cancer: correlation with angiogenic factors, p53, cathepsin D, hormone receptors and prognosis.
    Gasparini G; Toi M; Biganzoli E; Dittadi R; Fanelli M; Morabito A; Boracchi P; Gion M
    Oncology; 2001; 60(1):72-80. PubMed ID: 11150912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cathepsin D and breast cancer.
    Westley BR; May FE
    Eur J Cancer; 1996 Jan; 32A(1):15-24. PubMed ID: 8695224
    [No Abstract]   [Full Text] [Related]  

  • 7. Cathepsin D levels in primary breast cancers: relationship with epidermal growth factor receptor, oestrogen receptor and axillary nodal status.
    Sacks NP; Smith K; Norman AP; Greenall M; LeJeune S; Harris AL
    Eur J Cancer; 1993; 29A(3):426-8. PubMed ID: 8398346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoradiometric assay of pro-cathepsin D in breast cancer cytosol: relative prognostic value versus total cathepsin D.
    Brouillet JP; Spyratos F; Hacene K; Fauque J; Freiss G; Dupont F; Maudelonde T; Rochefort H
    Eur J Cancer; 1993; 29A(9):1248-51. PubMed ID: 8343262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cathepsin D in breast cancer: a tissue marker associated with metastasis.
    Rochefort H
    Eur J Cancer; 1992; 28A(11):1780-3. PubMed ID: 1389510
    [No Abstract]   [Full Text] [Related]  

  • 10. Cathepsin D concentration in breast cancer cytosols: correlation with disease-free interval and overall survival.
    Duffy MJ; Reilly D; Brouillet JP; McDermott EW; Faul C; O'Higgins N; Fennelly JJ; Maudelonde T; Rochefort H
    Clin Chem; 1992 Oct; 38(10):2114-6. PubMed ID: 1395002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation between cathepsin D expression and other prognostic factors in breast carcinomas.
    Shaheen RM; Miseljic S; Wiehle RD; Wittliff JL
    Clin Chem; 1995 Nov; 41(11):1585-91. PubMed ID: 7586547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between cathepsin-D and other prognostic factors in human breast cancer.
    Glikman P; Rogozinski A; Mosto J; Pollina A; Garbovesky C; Levy C
    Tumori; 1997; 83(3):685-8. PubMed ID: 9267489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of Cathepsin D expression in breast cancer: immunohistochemical assessment and correlation with radiometric assay.
    Eng Tan P; Benz CC; Dollbaum C; Moore DH; Edgerton SM; Zava DT; Thor AD
    Ann Oncol; 1994 Apr; 5(4):329-36. PubMed ID: 8075029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cathepsin D and prognosis in breast cancer.
    Tandon AK; Clark GM; Chamness GC; Chirgwin JM; McGuire WL
    N Engl J Med; 1990 Feb; 322(5):297-302. PubMed ID: 2296271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective study of the prognostic value of cathepsin D levels in breast cancer cytosol.
    Pujol P; Maudelonde T; Daures JP; Rouanet P; Brouillet JP; Pujol H; Rochefort H
    Cancer; 1993 Mar; 71(6):2006-12. PubMed ID: 8443752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic relevance of cathepsin D versus oestrogen receptors in node negative breast cancers.
    Granata G; Coradini D; Cappelletti V; Di Fronzo G
    Eur J Cancer; 1991; 27(8):970-2. PubMed ID: 1832905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of the tumor protease cathepsin D for the biology of breast cancer.
    Dian D; Heublein S; Wiest I; Barthell L; Friese K; Jeschke U
    Histol Histopathol; 2014 Apr; 29(4):433-8. PubMed ID: 24265119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cathepsin D: an independent prognostic factor for metastasis of breast cancer.
    Spyratos F; Maudelonde T; Brouillet JP; Brunet M; Defrenne A; Andrieu C; Hacene K; Desplaces A; Rouëssé J; Rochefort H
    Lancet; 1989 Nov; 2(8672):1115-8. PubMed ID: 2572846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of estrogen receptors and cathepsin D tissue detection in gastric adenocarcinoma.
    Theodoropoulos GE; Lazaris AC; Panoussopoulos D; Davaris P; Golematis BC
    J Surg Oncol; 1995 Mar; 58(3):176-83. PubMed ID: 7898114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low levels of basic fibroblast growth factor (bFGF) are associated with a poor prognosis in human breast carcinoma.
    Colomer R; Aparicio J; Montero S; Guzmán C; Larrodera L; Cortés-Funes H
    Br J Cancer; 1997; 76(9):1215-20. PubMed ID: 9365172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.